Pfizer said the demand for Pfizer’s coronavirus vaccine may increase its revenue. British Broadcasting Corporation.
They said that they want the demand for vaccines to stabilize, just like the demand for flu vaccines.
In the first three months of 2021, the vaccine generated $3.5 billion in revenue.
It is expected that this year’s vaccine revenue will exceed one third of Pfizer’s annual sales.
The forecast is based on a signed contract for 1.6 billion doses of vaccine to be delivered this year.
Pfizer said: “Based on what we have seen, we believe that the continued demand for the covid-19 vaccine is a possible outcome.”
The dual vaccine was Pfizer’s best-selling product in the first quarter.
Pfizer and BioNTech partners split the cost and revenue of vaccines in half.
Pfizer recently signed a contract with the United Kingdom to provide an additional 60 million doses by 2021.
Testing of the third dose of the vaccine is underway, and the United States is expected to give the green light to children aged 12 to 15.
In addition, the vaccine can be safely used in children from 6 months to 11 years old.